Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05246579 · ClinicalTrials.gov registry record
Prospective Evaluation of Pathways for Preterm Birth
A clinical trial of Preterm Birth and Cervix; Pregnancy, sponsored by John O'Brien, MD.
- Recruiting
- Registry status
- 240
- Enrollment target
- 1
- Study location
NCT05246579 is a study of Preterm Birth and Cervix; Pregnancy that is actively recruiting participants, run by John O'Brien, MD. The registered enrollment target is 240 participants, below the 4,623-participant average among 37 other Preterm Birth trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05246579, a study of Preterm Birth and Cervix; Pregnancy, is actively recruiting participants, sponsored by John O'Brien, MD.
- RECRUITING
- Registry status
- 240 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a single center, prospective cohort study of pregnant patients at high risk for spontaneous preterm birth: patient's with history of spontaneous preterm birth, patient's with a short cervix and patient's symptomatic for preterm birth will be included. A control cohort of nulliparous patients without a short cervix will be recruited to provide baseline data. Plan to enroll 240 patients identified through our ultrasound unit with goal of 60 patients in each group.
Conditions Studied
Study Locations (1)
Kentucky
- University of Kentucky - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2022-02-04 |
| Est. Completion | 2026-06-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05246579
The ClinicalTrials.gov registry entry for NCT05246579 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,623-participant average among 37 other Preterm Birth trials with a reported enrollment target (95% lower). The listed sponsor is John O'Brien, MD, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Preterm Birth appearing as the primary indexed condition, and to 0 interventions.
NCT05246579 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.
Frequently Asked Questions
What is clinical trial NCT05246579 about?
NCT05246579 is a clinical study titled "Prospective Evaluation of Pathways for Preterm Birth". This is a single center, prospective cohort study of pregnant patients at high risk for spontaneous preterm birth: patient's with history of spontaneous preterm birth, patient's with a short cervix and patient's symptomatic for preterm birth will be included. A control cohort of nulliparous patients...
What is the current status of trial NCT05246579?
This trial is currently recruiting. The enrollment target is 240 participants. The study started on 2022-02-04. Estimated completion is 2026-06-01.
What conditions does trial NCT05246579 study?
This clinical trial studies the following conditions: Preterm Birth, Cervix; Pregnancy.
Who is sponsoring clinical trial NCT05246579?
This trial is sponsored by John O'Brien, MD, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05246579 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Preterm Birth
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Transition From Donor Milk: a Feasibility Study
RECRUITING · NA
-
Improvement of PPROM Management With Prophylactic Antimicrobial Therapy (iPROMPT)
RECRUITING · Phase 4
-
Reducing Pregnancy Risks: The Mastery Lifestyle Intervention
RECRUITING · NA
-
Daily Aspirin vs Split Dosing in High-risk Pregnancies (DASH)
RECRUITING · Phase 1
-
Stress Phenotypes and Preterm Birth
RECRUITING · NA
-
The Effect of Sulfasalazine on CRH Levels in Pregnant Women
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.